Dr. Dean Jared Yamaguchi, MD

Dr. Yamaguchi practices at Ochsner Medical Center - New Orleans in New Orleans, Louisiana, part of Ochsner Health System.

Dr. Yamaguchi's NPI, 1316016397, was assigned on November 6, 2006. Dr. Yamaguchi holds North Carolina license 2013-01204.

Dr. Yamaguchi's primary practice is Ochsner Medical Center - New Orleans, at 1516 Jefferson Hwy, New Orleans, LA 70121 in Jefferson Parish. The practice phone is (504) 842-3000.

Dr. Yamaguchi's primary practice is Ochsner Medical Center - New Orleans in New Orleans, Louisiana, part of Ochsner Health System. Dr. Yamaguchi is also affiliated with Ochsner Lafayette General Medical Center. The medical group on file is Ochsner Health. Dmand AI also links Dr. Yamaguchi to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yamaguchi practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Yamaguchi's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dmand AI has Dr. Yamaguchi's licenses on file in 2 states: North Carolina and Florida.

CMS data shows 1,825 Medicare services from Dr. Yamaguchi across 34 procedure codes in 2024, for 810 Medicare patients. Medicare paid $150,881 for them.

CMS counts 810 Medicare patients who saw Dr. Yamaguchi in 2024. The largest group is 75 to 84, with 355 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yamaguchi's median patient age at 73, with 45% women.

In 2024, Dr. Yamaguchi wrote 395 Medicare Part D claims for 153 patients. 79% of them were for generic drugs. CMS names the drug for 290 of them, across 8 drugs with 11 or more claims each, at $62,947 in total drug cost. In 2023, CMS named 256 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Yamaguchi for performance year 2024, reported through an alternative payment model (APM). Dr. Yamaguchi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 16 procedures of leg revascularization (restoring blood flow) by Dr. Yamaguchi, more than 74% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Dr. Yamaguchi, published from 2011 to 2022. 2018 was the busiest year, with 3. The most frequent topics are Ischemia, Muscle, Skeletal and Endovascular Procedures. Dr. Yamaguchi has published most often in J Vasc Surg. Dr. Yamaguchi's most frequent co-authors are Brian H. Annex, MD, Keith Don Calligaro, MD and Rabih A. Chaer.

Dmand AI links Dr. Yamaguchi to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Aortic Root Aneurysm, Penetrating Atherosclerotic Ulcer and Acute Aortic Syndrome.

CMS Open Payments shows 73 general payments to Dr. Yamaguchi from 16 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 63% of the total. W. L. Gore & Associates, Inc. paid the most, $9,960.